Frequently Asked Questions

HLA is grateful to the Pennsylvania Attorney General Office's for its exercise of discretion in declining criminal prosecution of HLA's client, the owner of a Philadelphia pharmacy, that billed Medicaid nearly $600,000 for medications that were not dispensed to patients. Rather than criminally charge the owner, MFCU agreed to prosecute the pharmacy, a corporate entity, instead.

Prosecutors May Charge Both Individuals & Corporations

Criminal laws apply to "persons," which are defined to include both individuals and corporate entities, such as corporations and limited liability companies. Of course, a corporate entity would not serve a jail sentence. Therefore, given the goals of the criminal justice system, prosecutors primarily focus their efforts on individuals.

There are situations, however, where prosecutors will charge a corporate entity as part of a negotiated resolution. These scenarios are, by their nature, rare. And it is all the more rare that prosecutors will agree to charge a company instead of the individual running it.

PBM Inventory Discrepancies May Result in Fraud Investigations

Government contractors, such as payors and PBMs, are obligated to refer cases of actual or suspected fraud to the government for further investigations. With respect to government claims, referrals are often made to U.S. Attorney's Offices or State Medicaid Fraud Control Units (MFCUs).

In this case, the PBM referred the case to MFCU after an inventory audit uncovered discrepancies. Although the audit was relatively limited, it was mishandled by the Pharmacy and the PBM's concerns were not adequately addressed.

The Government's Investigation

Following the PBM's referral, the MFCU opened an investigation and served grand jury subpoenas on the Pharmacy, its employees, and distributors. Notably, the MFCU investigation was far broader than the PBM's inquiry, which is typically the case.

Ultimately, the MFCU found that the pharmacy and its owner had billed for medications that were not dispensed to patients, either because those medications had never been purchased, or because they had been returned to a wholesaler. In addition, the grand jury determined that the Pharmacy and Owner had billed brand medications while dispensing generic.

HLA's Defense Strategy

Because HLA's attorneys previously served as federal and state prosecutors, we deeply understand the considerations at play in the decision whether to file criminal charges. In this difficult case, Owner faced extremely significant risks apart from a potential prison term, including deportation from his home and family in this country.

We used all our skill and powers of persuasion to change that outcome. For example, in healthcare, given overlapping criminal and civil laws, different outcomes are often reached in cases involving similar conduct. We used examples from our national practice and cases across the country, in different jurisdictions, to appeal to the regulators in this case.

Ultimately, the Attorney General's Office agreed with HLA's arguments and declined to prosecute Owner, who obtained his citizenship while the case was pending.

Civil Settlement & Penalty

Of course, the resolution did not come without cost. Owner was required to reimburse the government for its losses, and agree to a 5-year Medicaid exclusion. Although the punishment was harsh, it could have been far worse.

Accordingly, we are highlighting this case as an example of the range of outcomes that can result from a PBM audit that is not handled correctly in the early stages.

HLA is Available to Help

If you are facing an aggressive PBM audit with inventory or other discrepancies, call or email before the audit gets referred to law enforcement. If you are the subject of an investigation by law enforcement, we can help stop charges being brought. And if you are the subject of filed criminal charges, we can help resolve the matter before trial or defend your innocence in court.

MORE ARTICLES BY CATEGORY

Get a Free Case REVIEW

100% Confidential & Secure. Your details are safe with us.

We'll speak soon!

In the meantime, why not find out more about us or visit our blog.

Alternatively, give us a call at (800) 345 - 4125

Oops! Something went wrong while submitting the form.

How Pharmacies Can Challenge Unfair PBM Audit Findings

PBM audits can leave pharmacies facing exaggerated findings, steep recoupments, and even network termination. With the right strategies and legal support, pharmacies can successfully challenge unfair results and protect their business.

Read More >>

Top Red Flags That May Trigger a PBM Audit

PBM audits can be disruptive, costly, and often triggered by high prescription volumes, dispensing irregularities, or claim activity. Pharmacies can reduce risks through strong documentation, compliance, and legal support to challenge unfair findings and protect network status.

Read More >>

Approaching the Telehealth Policy Cliff: Medicare Telehealth Flexibilities to Expire Next Week

Without further congressional action, COVID-19 era telehealth flexibilities are set to expire on September 30, 2025. Read more to learn about what’s set to change and key guidance for telehealth providers to prepare to adapt to pre-pandemic coverage rules.

Read More >>

OIG Doubles Down on Increased Oversight for RPM in New Report

On August 28, 2025, the US Department of Health and Human Services’ Office of the Inspector General published a report outlining billing data trends for remote patient monitoring (RPM) in Medicare, renewing its calls for increased oversight into RPM services. Learn more about the reports key findings.

Read More >>